ADHD PreSMA Response Inhibition Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorChildren's Hospital Medical Center, Cincinnati
About this trial
ADHD children have abnormal inhibitory control, meaning they have trouble stopping themselves from doing something they should not do. This ability to control involves an area in the brain called the pre-supplementary motor area (pre-SMA). Scientists have previously shown that the pre-SMA is abnormal in ADHD patients. In this study, we will use Transcranial Magnetic Stimulation (TMS) to stimulate the pre-SMA and determine the effects on measures that are related to inhibitory control.
Eligibility criteria
Qualifiers
ADHD diagnosis
Ages 12-17 years
Stimulant use is allowed but must be discontinued 24 hours prior to and during days of TMS visit
Disqualifiers
Medical conditions contraindicated or associated with altered TMS risk profile, including history of intracranial pathology, epilepsy or seizure disorders, traumatic brain injury, brain tumor, stroke, intellectual disability, cerebral palsy, neurodegenerative conditions, hearing impairment, metallic objects in the head or any other serious medical condition
Presence of any implanted medical devices (e.g., ports, shunts, stimulators, cochlear implants)
For biological females who are post-menarche, current pregnancy based on urine pregnancy test.
Baseline problem of hearing impairment or chronic tinnitus
Trial design
Treatments tested in this trial
- Active repetitive TMS
- Sham repetitive TMS
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov